Clinical Trial Update: COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease [NA]

View source ↗

Summary

A completed clinical trial update from Duke University examining COVID-19 vaccination hesitancy among adults with Sickle Cell Disease (NCT05998824).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Duke University | Conditions: Sickle Cell Disease, COVID-19 Vaccine | NA | Status: COMPLETED